福安药业 - Financials

福安药业 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
+Revenue	2.4B	2.6B	2.4B	2.5B	2.4B
Revenue Growth %	-9.7%	9.3%	-1.3%	3.6%	--
Total Revenue	2.4B	2.6B	2.4B	2.5B	2.4B
Cost Of Revenue	1.1B	1.2B	1.0B	911.0M	820.0M
+Gross Profit	1.3B	1.4B	1.4B	1.5B	1.5B
Gross Margin %	52.9%	53.4%	58.4%	62.9%	65.4%
Total Operating Cost	2.2B	2.7B	2.4B	3.1B	2.2B
Selling Expenses	563.0M	807.0M	881.0M	1.0B	1.1B
Admin Expenses	259.0M	242.0M	245.0M	213.0M	187.0M
Rd Expenses	153.0M	149.0M	143.0M	120.0M	86.9M
Finance Expenses	-6.9M	-2.3M	-2.3M	-333,100	-4.6M
+Operating Income	321.0M	298.0M	179.0M	-591.0M	241.0M
Operating Margin %	13.4%	11.3%	7.4%	-24.1%	10.2%
Non Operating Income	4.7M	1.6M	17.7M	3.6M	4.4M
Non Operating Expenses	13.3M	9.7M	6.9M	4.6M	4.1M
Investment Income	77.0M	77.4M	61.7M	51.7M	36.6M
Fair Value Change Income	-32.7M	408,300	417,300	746,500	3.3M
Asset Disposal Income	9,000	221.0M	4.8M	306,100	1.0M
Asset Impairment Loss	34.7M	244.0M	47.9M	831.0M	4.7M
Other Income	47.9M	52.3M	39.5M	33.3M	19.4M
Income Before Tax	312.0M	290.0M	189.0M	-592.0M	241.0M
Income Tax	34.0M	55.9M	-11.5M	17.6M	35.4M
+Net Income	278.0M	234.0M	201.0M	-610.0M	206.0M
Net Margin %	11.6%	8.8%	8.3%	-24.9%	8.7%
Net Income Attributable	280.0M	232.0M	205.0M	-297.0M	209.0M
Minority Interest	-1.7M	2.5M	-3.8M	-313.0M	-3.6M
Eps Basic	0.24	0.19	0.17	-0.25	0.18
Eps Diluted	0.24	0.19	0.17	-0.25	0.18

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash And Equivalents	846.0M	992.0M	689.0M	981.0M	853.0M
Trading Financial Assets	30.0M	5.1M	15.2M	20.9M	75.7M
Accounts Receivable	190.0M	251.0M	316.0M	319.0M	285.0M
Notes Receivable	26.8M	49.3M	72.7M	--	--
Notes And Accounts Receivable	217.0M	300.0M	389.0M	319.0M	285.0M
Prepayments	29.9M	33.3M	30.2M	24.9M	35.1M
Inventory	851.0M	708.0M	720.0M	632.0M	590.0M
Total Current Assets	2.1B	2.1B	1.9B	2.1B	1.9B
Long Term Equity Investment	1.0B	984.0M	876.0M	700.0M	647.0M
Fixed Assets	--	1.6B	999.0M	1.0B	795.0M
Fixed Assets Total	1.7B	1.6B	999.0M	1.0B	795.0M
Construction In Progress	--	156.0M	695.0M	441.0M	428.0M
Construction In Progress Total	114.0M	156.0M	695.0M	441.0M	428.0M
Intangible Assets	441.0M	402.0M	384.0M	382.0M	1.0B
Long Term Deferred Expenses	1.2M	1.8M	2.5M	1.1M	1.8M
Total Non Current Assets	3.9B	3.9B	4.0B	3.6B	4.0B
Total Assets	6.0B	6.0B	5.9B	5.7B	6.0B
Short Term Borrowings	333.0M	349.0M	406.0M	642.0M	477.0M
Accounts Payable	233.0M	306.0M	341.0M	248.0M	166.0M
Advance Receipts	3.0M	3.0M	2.9M	2.6M	--
Contract Liabilities	53.9M	51.1M	61.8M	57.1M	56.2M
Total Current Liabilities	1.2B	1.2B	1.3B	1.3B	1.1B
Long Term Borrowings	194.0M	487.0M	304.0M	264.0M	124.0M
Total Non Current Liabilities	353.0M	632.0M	644.0M	552.0M	356.0M
Total Liabilities	1.6B	1.8B	1.9B	1.8B	1.4B
Paid In Capital	1.2B	1.2B	1.2B	1.2B	1.2B
Capital Reserve	2.2B	2.2B	2.2B	2.2B	2.2B
Surplus Reserve	105.0M	81.1M	77.6M	77.6M	77.6M
Retained Earnings	847.0M	651.0M	482.0M	277.0M	634.0M
Minority Equity	2.3M	3.9M	1.4M	132.0M	455.0M
Equity Attributable	4.4B	4.1B	3.9B	3.7B	4.1B
Total Equity	4.4B	4.1B	3.9B	3.9B	4.6B

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020
Cash From Sales	2.4B	2.6B	2.4B	2.4B	2.4B
Tax Refunds Received	5.6M	10.7M	10.8M	12.1M	34.6M
Total Operating Cash Inflow	2.5B	2.7B	2.6B	2.5B	2.9B
Cash Paid For Goods	818.0M	734.0M	692.0M	597.0M	658.0M
Cash Paid To Employees	462.0M	433.0M	383.0M	351.0M	288.0M
Taxes Paid	208.0M	209.0M	166.0M	203.0M	248.0M
Total Operating Cash Outflow	2.2B	2.4B	2.3B	2.3B	2.7B
Operating Cash Flow	304.0M	329.0M	339.0M	257.0M	163.0M
Total Investing Cash Inflow	118.0M	182.0M	108.0M	257.0M	1.1B
Total Investing Cash Outflow	383.0M	276.0M	548.0M	606.0M	1.4B
Investing Cash Flow	-265.0M	-93.6M	-440.0M	-349.0M	-317.0M
Cash From Borrowings	485.0M	848.0M	589.0M	965.0M	643.0M
Dividends And Interest Paid	84.2M	94.0M	28.1M	84.1M	72.7M
Debt Repayments	665.0M	705.0M	801.0M	663.0M	205.0M
Total Financing Cash Inflow	590.0M	853.0M	660.0M	984.0M	647.0M
Total Financing Cash Outflow	818.0M	807.0M	832.0M	773.0M	320.0M
Financing Cash Flow	-228.0M	46.3M	-172.0M	211.0M	327.0M
Net Change In Cash	-188.0M	282.0M	-269.0M	117.0M	159.0M
Ending Cash Balance	748.0M	937.0M	654.0M	923.0M	806.0M
Capex	242.0M	216.0M	383.0M	413.0M	345.0M